about
CIP2A Promotes T-Cell Activation and Immune Response to Listeria monocytogenes InfectionOptimized design and analysis of preclinical intervention studies in vivoPrediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data.Novel Lignan and stilbenoid mixture shows anticarcinogenic efficacy in preclinical PC-3M-luc2 prostate cancer model.A practical comparison of methods for detecting transcription factor binding sites in ChIP-seq experimentsLabel-free quantitative phosphoproteomics with novel pairwise abundance normalization reveals synergistic RAS and CIP2A signaling.Longitudinal modeling of ultrasensitive and traditional prostate-specific antigen and prediction of biochemical recurrence after radical prostatectomy.Ovarian endometriosis signatures established through discovery and directed mass spectrometry analysis.Improved statistical modeling of tumor growth and treatment effect in preclinical animal studies with highly heterogeneous responses in vivo.Optimized detection of transcription factor-binding sites in ChIP-seq experiments.Erratum: Longitudinal modeling of ultrasensitive and traditional prostate-specific antigen and prediction of biochemical recurrence after radical prostatectomy.Innate immune activity is detected prior to seroconversion in children with HLA-conferred type 1 diabetes susceptibility.Community mining of open clinical trial data.Antiandrogens Reduce Intratumoral Androgen Concentrations and Induce Androgen Receptor Expression in Castration-Resistant Prostate Cancer Xenografts.The Hydroxysteroid (17β) Dehydrogenase Family Gene HSD17B12 Is Involved in the Prostaglandin Synthesis Pathway, the Ovarian Function, and Regulation of Fertility.Orphan G protein-coupled receptor GPRC5A modulates integrin β1-mediated epithelial cell adhesion.Targeted inactivation of the mouse epididymal beta-defensin 41 alters sperm flagellar beat pattern and zona pellucida binding.Liver lipid metabolism is altered by increased circulating estrogen to androgen ratio in male mouse.Castration induces up-regulation of intratumoral androgen biosynthesis and androgen receptor expression in an orthotopic VCaP human prostate cancer xenograft model.Combined ASRGL1 and p53 immunohistochemistry as an independent predictor of survival in endometrioid endometrial carcinoma.Secreted frizzled-related protein 2 (SFRP2) expression promotes lesion proliferation via canonical WNT signaling and indicates lesion borders in extraovarian endometriosis.Intra-tissue steroid profiling indicates differential progesterone and testosterone metabolism in the endometrium and endometriosis lesions.Susceptibility of low-density lipoprotein particles to aggregate depends on particle lipidome, is modifiable, and associates with future cardiovascular deathsePCR: an R-package for survival and time-to-event prediction in advanced prostate cancer, applied to real-world patient cohortsPP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cellsPharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapyRules for PP2A-controlled phosphosignalling and drug responsesCost-effective survival prediction for patients with advanced prostate cancer using clinical trial and real-world hospital registry datasetsCumulative Cancer Locations is a Novel Metric for Predicting Active Surveillance Outcomes: A Multicenter Study
P50
Q27314902-BB229669-D22E-4243-8473-ACF025DA3153Q28595545-024D789D-0BEF-4159-A3E0-0684C53EF8B6Q30490354-EE258910-3846-4FAB-AA46-9718228B7DA0Q31156045-7DD3AA79-8117-4DE1-884D-EAA48E901835Q33519192-9B301582-F4E0-453A-B118-9B2C1C87BEEFQ36273561-EF7E085B-5CAF-4C94-B0EA-DB46E3B10FA1Q37386391-4EBCA8FC-A4FC-4455-8524-2AF9B6E5270BQ38305206-7DEF7ED2-57E6-4049-B119-35A758685980Q39323097-21939C29-DA2E-4D83-9093-A2A84CED3D99Q39696007-D8170030-034A-4711-962D-CC68A9D6AAD9Q41988745-534EC7F5-CCC8-46A2-A010-B17539C64C31Q42236359-B668AB24-8000-440A-A4DD-E02DE2707CDEQ45943893-99D9E503-B9FB-44A5-BE15-48BA16408E32Q47415574-80DF1E91-9E84-4008-BB11-066CC13D7301Q48030480-A6108688-AB4B-495C-B576-7E4C59778CB4Q48316176-863274F2-07A8-4851-87D5-C39A6DBE2F67Q48555062-0B8F8AC5-6694-49DE-A1B7-7806124BEEE5Q50750757-B77392E8-127B-4BA0-B2B1-057FC9520D73Q51075713-4746C637-0D59-47A8-9EC0-EB3847960968Q52682592-4ED9D91E-6FCF-4530-A2BE-06A6977492F8Q52692571-BA028ADC-1173-48E5-BF80-C76EB8618983Q53026500-72A2C9F1-C1C2-4BB8-AD6D-BB981EDA2122Q57176033-F5284FD1-E7AD-4D1C-8F00-4D946E2D907FQ60211781-D4D090FD-ECA8-4A43-BF77-9B612E811D4CQ60211787-81CBAC41-C130-4F92-BD36-7D2A17502FAAQ61798926-E7F985C9-3995-4B00-84F2-F0AB62D58616Q63484963-D677B328-B836-490E-8F41-0B835BB4279EQ91549220-AE383C2E-139D-413D-AA59-A13359D8382AQ92114391-502820D5-417A-4DA0-80EA-9BEAAC189FD5
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Teemu D Laajala
@ast
Teemu D Laajala
@en
Teemu D Laajala
@es
Teemu D Laajala
@nl
Teemu D Laajala
@sl
type
label
Teemu D Laajala
@ast
Teemu D Laajala
@en
Teemu D Laajala
@es
Teemu D Laajala
@nl
Teemu D Laajala
@sl
altLabel
Daniel Laajala
@en
Teemu D Laajala
@en
Teemu Daniel Laajala
@en
Teemu Laajala
@en
prefLabel
Teemu D Laajala
@ast
Teemu D Laajala
@en
Teemu D Laajala
@es
Teemu D Laajala
@nl
Teemu D Laajala
@sl
P108
P106
P21
P31
P496
0000-0002-7016-7354